As I reviewed in PMS: What is it anyway? there are
4 areas
of studies that deal with problems associated with menstrual cycle: Irritable bowel syndrome (IBS), PMS, PMDD, and Catamenial Epilepsy. Here, I will review the underlying mechanism for each and see how related they are.
Underlying
mechanism: Catamenial Epilepsy
Seizures are the clinical manifestation of
abnormal, excessive excitation and synchronization of a population of cortical
neurons. According to a review by Three
patterns of catamenial epilepsy. (A G Herzog, P Klein, B J Ransil, 1997), "Estradiol inhibits gamma-aminobutyric
acid (GABA) and potentiates glutamatergic transmission. It increases neuronal
metabolism and discharge rates. It promotes kindling and animal experimental,
as well as clinical seizure occurrence. Progesterone metabolites such as
allopregnanolone, in contrast, are potent barbiturate-like ligands at the
GABA-chloride ionophore. Progesterone reduces neuronal metabolism and discharge
rates, and suppresses kindling, epileptiform discharges, and experimental as
well as clinical seizures." The earliest article they cite is dated 1955 (Almqvist
R. The rhythm of epileptic attacks and its relationship to the menstrual cycle.
Acta Psychiatr Neurol Scand 1955;3O(Suppl 105):l-116).
It is safe to say the role of estradiol and
progesterone in epilepsy are well understood and established. It very well
explains the observations that seizure frequency decreases when progesterone is
high, and increases when progesterone is low and estradiol is high.
In more recent Hormones and Epilepsy, (Mira Katan 2011) reviewed and portrayed
more complex picture of hormone actions in brain, but it suggested nothing that
contradicts the above understanding. Also NIH-sponsored clinical
trial pretty much
confirmed the efficacy of progesterone therapy: Neuroendocrine
aspects of catamenial epilepsy. (Doodipala
Samba Reddy, 2012) reported
"Experimental studies have shown that neurosteroids
confer greater seizure protection in animal models of catamenial epilepsy,
especially without evident tolerance to their actions during chronic therapy.
In the recently completed NIH-sponsored, placebo controlled phase 3 clinical
trial, Progesterone therapy proved to be beneficial only in women with perimenstrual
catamenial epilepsy but not in non-catamenial subjects."
Magnesium connection
Another well established understanding of
epilepsy is low magnesium model of seizure. As reviewed in Surface charge
impact in low-magnesium model of
seizure in rat hippocampus. (Dmytro Isaev, Gleb Ivanchick, Volodymyr Khmyz,
Elena Isaeva, Alina Savrasova, Oleg Krishtal, Gregory L. Holmes, Oleksandr
Maximyuk. J Neurophysiol. 2012), "The low Mg2+ model of
epilepsy was developed several decades ago, and since that time has been widely
used as a model to test antiepileptic drugs. This model of epilepsy has
clinical relevance as Mg2+ deficits can increase seizure susceptibility
to proconvulsant stimuli or even cause seizures in humans. There is also an evidence
that Mg2+ concentration in serum and cerebrospinal fluid is lower in
patients with generalized tonic-clonic seizures. In addition, intravenously
injected Mg2+ has an anticonvulsant effect in animal models of
epilepsy and is used to treat seizures, particularly in women with eclampsia."
According to a review Can magnesium supplementation
reduce seizures in people with epilepsy? A hypothesis. (Yuen AW, Sander
JW, Epilepsy Res. 2012), "There are case reports of seizures being
controlled with magnesium supplementation in people with specific conditions,
and recently in an open randomized trial, children with infantile spasms
responded better to adrenocorticotropic hormone (ACTH) plus magnesium than to
ACTH alone."
As Ray
Peat (Ph.D.) emphasized in his booklet Progesterone
in Orthomolecular Medicine (1993), many of the biological effects of estrogen
and progesterone are reflection of their roles in promoting intracellular
calcium ions (Ca2+) and magnesium ions (Mg2+)
respectively, and progesterone's role as a rapid acting calcium blocker.
One thing that is known to happen when
progesterone starts to secrete after ovulation is a slight rise in body
temperature, indicating an increase in the basal metabolic rate and oxygen
consumption, which requires higher magnesium ions involved in more than 300
biochemical processes.
What this means is that from the day after ovulation
to a few days before menstruation, progesterone is secreted and it helps
intracellular use of magnesium, and if magnesium intake is not adequate, circulating
available magnesium depletes more and more until progesterone secretion stops,
at which point, the body looses progesterone's help to boost intracellular Mg
under the worst Mg deficiency. That is probably why Catamenial Epilepsy or PMS
in general is most severe during the days when progesterone is dropping (premenstrual
days) rather than at the peak of progesterone or at ovulation when
estradiol/progesterone ratio is at the worst, which you may expect if
progesterone or estrogen dominance is the direct cause of PMS or the epilepsy.
After a while the body's Mg requirement goes down and circulating available
magnesium level recovers, and the symptoms disappear. If there is a severe Mg
deficiency, however, even with progesterone's help, your body may struggle with
Mg deficiency a lot longer. When looking at PMS this way, it makes sense for
both progesterone and magnesium supplementation during this period can help
reduce the severity of the symptoms or make it disappear all together.
Magnesium levels and menstrual cycle
Sex steroid hormones modulate
serum ionized magnesium and calcium levels throughout the menstrual cycle in
women. (O
Muneyvirci-Delale, V L Nacharaju, B M Altura, B T Altura, 1998) measured
the serum concentrations of the sex steroid hormones with respect to the
concentrations of the biologically active fractions of magnesium and calcium
during the different phases of the menstrual cycle for healthy reproductive age
women. In each woman, there was a comparatively high ionized Mg level coincident
with the early follicular phase, a statistically significant decrease in
ionized Mg around the time of ovulation, a significant decrease in ionized and
total Mg when the serum progesterone concentration peaked, and a significant
increase in the serum Ca2+/Mg2+ ratio at both the ovulatory and luteal phases.
They concluded "The changes in serum concentrations of these important
physiologically active cations, in the range at which they occur, can affect
such entities as the vasculature, synaptic transmission, and
excitation-secretion coupling and thus can produce the well-known premenstrual
syndromes during the luteal phase in women who are somewhat deficient in Mg or
in those who have an unusually increased Ca2+/Mg2+ ratio."
Interestingly, Premenstrual increase of
intracellular magnesium levels in women with ovulatory, asymptomatic menstrual
cycles. (F
Facchinetti, P Borella, M Valentini, L Fioroni, A R Genazzani,1988) did not find fluctuation
in the circulating magnesium in the plasma, but they have shown intracellular
Mg levels measured in lymphocytes and polymorphonucleated cells increase toward
the end of progesterone secreting period compared with the other periods of the
cycle, which is consistent with the role of progesterone to promote
intracellular Mg. Perhaps, it is important to keep circulating magnesium in the
plasma steady at an adequate level to avoid PMS, as this study seems to
suggest.
It's been well known that modern diet is
deficient of magnesium (Dietary magnesium intake in a national sample of US adults. Earl S Ford, Ali H Mokdad 2003), and
magnesium supplementation can improve a wide range of poor health conditions
and vulnerabilities. In 1988, R J
Elin (Clinical Pathology Department, National Institutes of Health,
Bethesda, Maryland) reviewed the importance of magnesium and the
consequences of a chronic latent magnesium deficiency in the US in Magnesium metabolism in health anddisease as follows:
A large segment of the U.S. population may
have an inadequate intake of magnesium and may have a chronic latent magnesium
deficiency that has been linked to atherosclerosis, myocardial infarction,
hypertension, cancer, kidney stones, premenstrual syndrome, and psychiatric
disorders.
It's been more than 20 years since, and 40
years since Seelig and Durlach, in the early sixties, based on long-term
balance studies of intake and excretion of magnesium, recommended a daily
magnesium intake of 6 mg/kg/day (Seelig, M.S: The requirement of magnesium by
the normal adult. Summary and analysis of published data. Am J Clin Nutr 14(6),
342-390 (1964)). Yet, this knowledge is by no means shared or promoted in
general public nor among clinicians, while the evidence is mounting: magnesium
supplements will prevent cardiovascular diseases better than cholesterol
lowering statin drugs and blood thinning aspirin, reduces inflammation, and
improves emergency room survival rates (The therapeutic use
of magnesium in anesthesiology, intensive care and emergency medicine: a
review. Laurent Dubé, Jean-Claude
Granry. 2003), for example.
Underlying
mechanism: Constipation
There are various factors that influence the
bowel habits and most of them can be altered independent of menstrual cycle
such as water, fiber, magnesium, prostaglandins, microbiota of colon (bad v.s.
good microbes), stress, physical activities, etc. although they may be inter-related in various ways
with menstrual cycle as in the case of magnesium level as reviewed above.
Association between dietary
fiber, water and magnesium intake and functional constipation among young
Japanese women. 2007 by K
Murakami, S Sasaki, H Okubo, Y Takahashi, Y Hosoi, M Itabashi reported "Low
intakes of water from foods and magnesium are independently associated with an
increasing prevalence of functional constipation among a population whose
dietary fiber intake is relatively low." Yet for many, menstrual cycle seems
the most dominant factor. Relationships between symptoms, menstrual cycle and orocaecal transit
in normal and constipated women. (G K Turnbull, D G Thompson, S Day, J Martin, E Walker, J E
Lennard-Jones 1989) reported "... patients noted variation in
constipation during the menstrual cycle, in all cases this comprised an
improvement in symptoms just before or during menstruation." That
certainly was my case.
Progesterone receptor types
When menstrual cycle is involved, the first
place researches look is the hormones, in this case progesterone. One of the factors making the hormone research complicated is the
involvement of multiple receptor types of each hormone. The function of a
hormone is not determined by the hormone itself. It is dependent on the
receptor types expressed at the cell. For progesterone, there are receptor type
A (PRA) and B (PRB), and when PRA is dominating in tissue cells, progesterone
does not work (Mg intake, for example). Uterine contraction necessary for labor is initiated by increase of PRA (Nuclear
progesterone receptors in the human pregnancy myometrium: evidence that
parturition involves functional progesterone withdrawal mediated by increased
expression of progesterone receptor-A., Merlino, et. al., 2007). In intestines, when PRA is low relative
to PRB, intestines become less active, resulting in constipation. In other
words, the uterine contraction required for labor as well as colon movement
depends on the progesterone receptor A to block progesterone action, and this
is true for many other smooth muscle cells (Broad tissue expression of membrane
progesterone receptor Alpha in normal mice. Shaojin You, Lian Zuo, Vijay Varma 2010).
A group of researchers lead by Jose Behar, (Rhode Island Hospital and Warren Alpert
Medical School at Brown University), have been pursuing this subject and have
demonstrated that progesterone affects the colon muscle of constipation
sufferers far more than that of normal control subjects due to overexpression
of PRB. They also demonstrated that
normal colon cells exposed to extremely high level of progesterone for 6 hours
become abnormal in terms of progesterone receptor. However, the fact remains
that not everyone get constipated during progesterone is secreted. The
incidence of constipation during pregnancy is only approximately 25% despite high
serum progesterone levels. In other words, exposure to high level of
progesterone alone is not enough to cause constipation in naturally occurring
conditions. Something else is involved to cause the over expression of
progesterone receptor B and/or under expression of PRA
(Overexpression
of progesterone receptor B increases sensitivity of human colon muscle cells to
progesterone. Ling
Cheng, Victor
Pricolo, Piero
Biancani, Jose Behar
2008; Progesterone
receptors and serotonin levels in colon epithelial cells from females with slow
transit constipation. M Guarino, L Cheng, M Cicala, V Ripetti, P Biancani, J Behar 2011).
To make some observations from my personal
experience, there seems some switching mechanism to
turn on normal colon
movement as well as labor. Every month, I could feel
that switching 2 days
before the flow started, and that was a big relief. I
felt my entire body was going back to normal. Sometime, I also noticed one time
release of distinctive fragrant odder in urine, which accompanied at that very
moment. Interestingly, it did continue even after my surgical menopause for
years, indicating it did not originate from ovaries or uterus.
Role of prostaglandins
(they promote inflammation and pain. Pain medicines, like Aspirin, inhibit
enzymes such as COX-1 and COX-2 that are necessary to make prostaglandins.) and their
receptor types in colon movement is also known. There are variety of
prostaglandins and most of them (e.g. PGF2α and PGE2) promote contraction of
smooth muscles (blood vessels, digestive tract, uterus, etc.). One exception is
PGE2 in combination with the receptor EP2 that relaxes intestines, while PGE2
with receptor EP1 promotes contraction of smooth muscles of intestines as well
as uterus (Characterization of the EP receptor types
that mediate longitudinal smooth muscle contraction of human colon, mouse colon
and mouse ileum. S E Fairbrother,
J E Smith, R A Borman, H M Cox. 2011). So far, I have not seen IBS studies that checked the receptor type along with PGE2, while PGE2 have been blamed for both constipation and diarrhea. Another interesting research direction on PGE2 is that with receptor type EP3 in brain, it may cause mental symptoms of PMS (Prostaglandins
and premenstrual syndrome. N
Koshikawa, T Tatsunuma,
K Furuya, K Seki 1992; [The
mechanism of prostaglandin effects on GABAa receptor at molecular level.] Sugimoto 2009).
Magnesium connection
(a) increased number of bowel movements
(b) increased percentage of stool water
(c) increased stool volume
(d) increased stool Mg2+
(e) increased total stool 24-h prostaglandin E2
(PGE2) in a dose dependent manner
With this results, they thought that magnesium's
laxative effect may have something to do with the prostaglandin E2 (PGE2)
increase.
Water inside colon/stool can be increased
either by retaining water inside colon blocking absorption, or by moving water
out of blood vessel into inside intestinal tube. In general, there are two
types of laxatives, osmotic and stimulant. Magnesium salts are osmotic laxative
that alter the osmotic pressure inside intestinal tube by its own electrochemical
property in favor of increasing water inside colon. A stimulant laxative such
as Senna, on the other hand, stimulates/irritate colon wall to induce
biochemical reactions at intestinal mucosa or nerve endings to retain more
water and/or stimulate peristaltic action of intestines (see Laxative in Wikipedia).
The osmotic pressure theory of magnesium
laxative tells that the higher concentration of magnesium ions in colon
relative to colon wall and blood vessel surface tissues would result in more
water in colon. Furthermore, magnesium absorbed by the tissues increases
intracellular Mg+ which increases aquaporin-3 that aid in water transport, from
the blood to inside colon, in this case. Aquaporins (AQPs) are membrane
channels that transport water within the human body, and AQP3 is predominantly
expressed in colon to transport water between blood vessel in colon wall and inside
colon (The
elucidation of the function and the expression control mechanism of aquaporin-3
in the colon. Ikarashi N. 2013).
How about PGE2 that seems to increase with
Magnesium laxatives as reviewed above? There are many conditions that lead to
PGE2 increase, and stimulant laxative is one of them and menstruation is another which increases both PGE2 and PGF2a in uterus right next to colon, and causes reduced blood circulation in the area and more frequent bowel movements.
To put these observations together with the
menstrual cycle dependency of constipation, the following picture emerges: If
there is a magnesium deficiency (it's common), since progesterone promotes Mg
absorption to increase intracellular Mg, leaving less inside colon resulting in
altered osmotic pressure, while increased Aquaporin-3 facilitates water absorption
as well. The result is harder stool and
constipation. Also it is conceivable that magnesium deficiency may be a cause of increased
progesterone receptor type B, which might be designed to make progesterone work
harder to compensate for the magnesium deficiency, to the extent the colon
movement is slowed.
Effects of Microbiota of Intestines
It
is a popular notion that eating probiotics such as yogurt promote good
bowel habits, and bad microbiota of intestines such as yeast infection
can lead to poor health. Today, researchers
are finding out all sorts of health problems, including obesity and mental
health, are associated or caused by some bad microbiota of intestines (yeast = Candida
albicans is one of them). Magnesium deficiency is one of the results and a cause of yeast infection (Normocalcemic tetany and candidiasis. L Galland 1985). Inflammation
and prostaglandins are also affected by bad microbiota of intestines.
[Predominance of constipationin subjects with hydrogen-consuming intestinal flora]. (Dima et. al. 2012) reported "IBS patients with low hydrogen production on lactulose breath test were 6 times more frequently constipated.
Interestingly, according to
The
hypersensitivity to colonic distension of IBS patients can be transferred to
rats through their fecal microbiota (L. Crouzet, et. al. 2013), sensitivity to colonic distension of IBS patients can be transferred to rats by the fecal microbiota (more sulfate-reducing bacteria and Enterobacteriaceae and less bifidobacteria).
Whatever the cause,
constipation itself has a certain negative health
consequences such as depression and anxiety, not to mention the negative health
consequences of magnesium deficiency and internally generated toxins staying longer inside the body. It is best to take care of it early with laxatives (preferably magnesium based) when necessary.
Diarrhea
So, constipation implies more or less normal hormonal balance with magnesium
deficiency, it looks like. A menstrual cycle without progesterone (therefore estrogen dominance) on the other hand, does the opposite
promoting diarrhea according to my experience.
Underlying
mechanism: PMS
Magnesium deficiency + estrogen dominance
I have seen various approaches to PMS. To lay
out my conclusion up front, I arrived at the magnesium deficiency + estrogen
dominance theory of PMS. As I reviewed above in Catamenial epilepsy and Irritable
Bowel Syndrome/constipation sections, magnesium deficit plays a major role
whether there is hormonal imbalance or not, and it exacerbates hormonal
imbalance, if it exists, or it can cause hormonal imbalance.
Abraham (Nutritional factors
in the etiology of the premenstrual tension syndromes. G E Abraham 1983) was the
first one who proposed magnesium deficiency as the underlying causes as well as
the aggravation factor of the PMS symptoms, and demonstrated the efficacy of a
nutritional supplement program emphasizing magnesium and vitamin B6 in early
1980's. More recently, the efficacy of magnesium + B6 in reducing PMS symptoms
was replicated by researchers in Iran (Evaluating the
effect of magnesium and magnesium plus vitamin B6 supplement on the severity of
premenstrual syndrome. Fathizadeh N, Ebrahimi E, Valiani M, Tavakoli N, Yar
MH. 2010), and in Italy (Pilot study of the efficacy
and safety of a modified-release magnesium 250 mg tablet (Sincromag) for
the treatment of premenstrual syndrome. 2007). The efficacy
of Magnesium supplementation has been also demonstrated with menstrual migraine (Magnesium prophylaxis
of menstrual migraine: effects on intracellular magnesium. Facchinetti
F, Sances G, Borella P, Genazzani AR, Nappi G. Headache. 1991) and premenstrual
symptoms of fluid retention (Magnesium supplementation
alleviates premenstrual symptoms of fluid retention. Walker AF, De Souza
MC, Vickers MF, Abeyasekera S, Collins ML, Trinca LA. J Womens Health. 1998).
Use of progesterone goes back even farther. By 1977, Katharina Dalton, a British doctor, has written The Premenstrual
Syndrome and Progesterone Therapy based on her success with natural
progesterone. Progesterone in
Orthomolecular Medicine by Raymond Peat (Ph.D.) published in 1993 explained
PMS as part of estrogen dominance syndrome, where estrogen /
progesterone balance is lost due to too much estrogen, too little progesterone
or both. He also
pointed out that many of the progesterone's biological effects are derived from
its role in increasing intracellular Magnesium ions as well as zinc and oxygen
and reducing intracellular water.
Effects of
hormones on PMS have been studied by measuring PMS severity, estradiol and progesterone
levels throughout the cycle. It has also been studied by adding or blocking
estradiol and/or progesterone. They have consistently shown high estrogen level
overall or during premenstrual days relates to worse PMS symptoms even with
normal or seemingly a higher than
normal level of progesterone (clearly, it is estradiol/progesterone ratio
that matters). They have also shown early drop
or a lower level of progesterone in premenstrual days correlates with worse PMS
symptoms.
When you look at the history of PMS research,
many have struggled trying to make sense starting with a very simple minded
line of thinking: If it happens when progesterone is secreted, progesterone must
be causing it. From this, many doctors are convinced that progesterone is the
culprit and they try to stop ovulation by surgically or chemically inducing
menopause so that no progesterone secretion occurs. For those doctors, it is
unthinkable to use progesterone to alleviate PMS. Those researchers and doctors
apparently did not examine the fact closely enough to see it happens when
progesterone starts to drop, to say nothing about the poor out come of trading
PMS with menopausal symptoms and the associated health risks. Realizing that,
some researcher thought it must be a progesterone withdrawal symptoms. It,
however, cannot explain those cases that occur right after ovulation when
estrogen is high and progesterone is barely starting to secrete. That can be explained
by estrogen dominance. Now if you look at the estradiol and progesterone ratio,
you would realize that during the first half of the cycle (from the start of
the menstruation to ovulation) there is no progesterone secretion, and estrogen
slowly rises and surges right before ovulation. In other words, there is an
extreme estrogen dominance right before ovulation, yet that is the time most women
feel the best, no PMS.
To explain this pattern, you need to look at magnesium deficiency in relation with estrogen / progesterone patterns as I have discussed earlier. If there is a magnesium deficiency, progesterone can still help by increasing intracellular magnesium, but it further depletes the circulating magnesium, and a drop of progesterone level means a drop of intracellular magnesium, at the moment circulating magnesium is depleted, therefore magnesium supplementation is also effective. In addition, as I reviewed in the Constipation section, magnesium deficiency + progesterone can lead to constipation, another complication factor of PMS.
Underlying
mechanism: PMDD
Effects of Microbiota of Intestines
Another source of toxin is the bad bugs in your intestines.
Intestinal
microbiota, probiotics and mental health: from Metchnikoff to modern advances:
Part II - contemporary contextual research. (Bested, et. al., 2010) reviewed endotoxins such as lipopolysaccharide endotoxin (LPS) from disease causing bacteria and D-lactic acid from carbohydrate fermentation, and pointed out that they can cause mood disturbances, anxiety, aggression, impaired memory, and fatigue. Furthermore, they also pointed out that a
deficiency of magnesium and zinc reduces the healthy diversity of gut microbiota and increases the systemic endotoxin
burden.
So, it goes like this: After ovulation (high estrogen = high Ca2+/Mg2+), body temperature rises slightly (this probably favors the bad bugs), progesterone secretes (helps intracellular magnesium to increase to counteract high Ca2+), less magnesium left in intestines (another factor to favor the bad bugs as well as constipation), endotoxin starts to increase (you starts to feel bad), circulating magnesium starts to deplete (your body start to struggle with magnesium deficiency), progesterone starts to drop (now your cells cannot get enough magnesium at all and Ca2+/Mg2+ gets high). It keeps getting worse until the body temperature drops, constipation goes a way, new cycle starts with menstruation, and things calm down with low hormonal activities (both estrogen and progesterone) and less active endotoxin producing microbes, and circulating magnesium level recovers.